IDT vs iQSTEL
IDT and IQST side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IDT and IQST compare
IDT is the larger company, worth 6.9 times as much as iQSTEL ($2.0B against $294M).
iQSTEL grew revenue faster over the last twelve months (39.3% versus 5.4% for IDT).
IDT keeps more of each dollar of sales as profit, with a net margin of 6.7% compared with −2.2% at iQSTEL.
IDT pays a dividend yielding 0.33%; iQSTEL does not pay one.
IDT scores higher on the StockData Score (18 against 6 for iQSTEL), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IDT | IQST |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $294M |
| Share price | $81.02 | $0.730 |
| Change, 1 year | 57.4% | −84.0% |
| Change, 5 years | 38.5% | −98.2% |
| Beta (5Y) | 0.31 | 0.89 |
| Employees | 1,971 | 100 |
| StockData Score | ||
| Total score | 18 (better) | 6 |
| Valuation score | 0 | 0 |
| Growth score | 4 (better) | 2 |
| Performance score | 5 (better) | 1 |
| Health score | 6 (better) | 3 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 23.4× | – |
| P/S | 1.6× | 0.7× (better) |
| P/B | 5.3× (better) | 17.1× |
| EV/EBITDA | 12.7× | – |
| P/FCF | 29.6× | – |
| PEG | 0.78 | – |
| FCF yield | 3.4% (better) | −1.3% |
| Fair value | $53.85 | – |
| Margin of safety | −50.5% | – |
| Growth | ||
| Revenue growth (TTM) | 5.4% | 39.3% (better) |
| Revenue growth, 5Y average | −2.2% | 37.4% (better) |
| Net income growth (TTM) | 13.9% | – |
| EPS growth (TTM) | 15.0% | – |
| EPS growth, 5Y average | −1.3% | – |
| Profitability | ||
| Gross margin | 38.3% (better) | 2.7% |
| Operating margin | 9.3% (better) | −1.3% |
| Net margin | 6.7% (better) | −2.2% |
| FCF margin | 5.2% (better) | −0.99% |
| Return on equity | 25.4% (better) | −56.0% |
| Return on invested capital | 75.4% (better) | −23.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.15 (better) |
| Current ratio | 1.86 (better) | 1.09 |
| Altman Z-score | 6.52 | 12.21 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 0.33% | – |
| Payout ratio | 7.5% | – |
| Years of dividend growth | 2 | – |
| Shareholder yield | 0.33% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 56.5% | 0.06% |
| Held by insiders | 17.6% | 0.00% |
| Insider net buying, 12 months | −$7.7M | – |
| Short interest, % of float | 4.9% | 0.10% |
Go deeper
- IDT stock overview
- IDT income statement
- IDT valuation and score
- IQST stock overview
- IQST income statement
- IQST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.